Reagencie a diagnostika


  • FastGene® NGS-Library Quantification Kit -The accurate quantification of next-generation sequencing (NGS) Illumina® Libraries is very important for maximizing data output and quality on every sequencing run. The FastGene® NGS-Library Quantification Kit contains all reagents for an accurate and reproducible qPCR-based quantification of  Illumina® Libraries: The Kit comes with specific primers, qPCR Master Mix and DNA Standards.
  • PCRBIO HS VeriFi™ Polymerase - is a versatile and robust proofreading enzyme with AptaLock™ hot start technology for highly precise PCR. Improved DNA binding and increased processivity give significant improvements in speed, yield and sensitivity while also increasing PCR success rates of long and challenging templates.

  • PCRBIO VeriFi Polymerase - 100x higher fidelity than Taq DNA polymerase. Robust high fidelity enzyme engineered for all PCR applications where greater sequence accuracy is required, such as cloning, site-directed mutagenesis and sequencing

  • Hledáme posilu do našeho týmu na místo ochodního zástupce - více informací zde

  •   NEXT GENERATION KITY pro izolaci nuklových kyselin od firmy BioECHO-nová technologie- významně méně kroků ve srovnání s protokoly "bind–wash–elute" (o 50-70% méně kroků) a tím drasticky zkrácený čas potřebný k izolaci (2-5xrychlejší, v závislosti na aplikaci)

Mynox®Gold Mycoplasma Elimination 2 v 1 - double Strenght (2 aplikace)

Mynox®Gold Mycoplasma Elimination, 2 v 1 - double Strenght, (2 aplikace) Zobrazit větší


Minerva Biolabs

Cena bez DPH 4 959 Kč

Cena s DPH 6 000 Kč

Položit dotaz

Více informací


Mynox® Gold represents the further development of the classical Mynox®. Mynox® Gold is a combination of a standard antibiotic and the biological Mynox® reagent. One application comprises of a starter treatment that eliminates most of the mycoplasma particles without harming the cells. The main treatment kills all remaining mycoplasma.


No cytotoxicity – cytotoxicity is basically not detectable for most cell types. Most cell lines do not show any changes in morphology during treatment.

Low resistance risk – due to the combination of an antibiotic and a reagent showing a biophysical mode of action directly eliminating the mycoplasma, formation of resistances against Mynox® Gold is most unlikely.

Highly effective – the ratio for a permanent eradication is close to 100 %.

Recommended Use / Scope

Mynox® Gold is intended for research use only. Not applicable for clinical treatment. Not applicable for the direct treatment of enveloped viruses or cells harboring Chlamydia or other bacteria as host systems. The antibiotic portion of the product might affect the integrated microorganisms.

Kit Components

1 application of Mynox® Gold contains 1 vial for the starter treatment and 3 vials for the main treatment. Each vial contains 500 µl as a sterile, ready-to-use solution.

Package Sizes

1 application can be used to cure one cell culture permanently from mycoplasma burden.

  • Cat. No. 10-0201 2 applications
    Cat. No. 10-0501 5 applications
    Cat. No. 10-1001 10 applications
Result Evaluation

Elimination success should be verified with a suitable mycoplasma detection system, e.g. Minerva Biolabs’s Venor®GeM Mycoplasma PCR Detection Kits.

Required Consumables

6-well tissue culture plate or small tissue culture petri dish (6 mm Ø)

Regular cell culture plastics

Required Lab Devices

Regular cell culture equipment (incubator, centrifuge, pipettes, etc.)

Shelf Life and Storage

Kit components are maintainable at +2 to +8 °C for at least 6 months.

Fig. Cytotoxicity of Mynox® Gold on contaminated cells. Adherent cell lines (Vero, ML/S MDBK and RK13) were treated with Mynox®Gold according to the protocol 4 days of incubation. The cultures were inactivated and stained as described by Flick & Gifford. Untreated cultures had been used as reference (100 %).